Long-Term Durability of the Next-Generation Acurate neo 2 Transcatheter Heart Valve: Insights From Bench Testing to 25 Years

Janarthanan Sathananthan; Uri Landes; Lionel Flaction; Arnaud Humair; Stéphane Delaloye; Stefan Toggweiler; Lars Søndergaard; David A. Wood; John G. Webb

doi:10.1016/j.jcin.2020.10.030

Long-Term Durability of the Next-Generation Acurate neo 2 Transcatheter Heart Valve: Insights From Bench Testing to 25 Years

Janarthanan Sathananthan^*, Uri Landes, Lionel Flaction, Arnaud Humair, Stéphane Delaloye, Stefan Toggweiler, Lars Søndergaard, David A. Wood, John G. Webb

^*Corresponding author for this work

Clinical Departments

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	586-588
Number of pages	3
Journal	JACC: Cardiovascular Interventions
Volume	14
Issue number	5
DOIs	https://doi.org/10.1016/j.jcin.2020.10.030
State	Published - 8 Mar 2021

Access to Document

10.1016/j.jcin.2020.10.030

Cite this

@article{64ff4395de2d42d4895d57b4871e63d1,

title = "Long-Term Durability of the Next-Generation Acurate neo 2 Transcatheter Heart Valve: Insights From Bench Testing to 25 Years",

author = "Janarthanan Sathananthan and Uri Landes and Lionel Flaction and Arnaud Humair and St{\'e}phane Delaloye and Stefan Toggweiler and Lars S{\o}ndergaard and Wood, {David A.} and Webb, {John G.}",

note = "Funding Information: This study was a purely bench study with no human or animal participants, and ethics approval was not required. No patient data were used in this study. Dr. Sathananthan is a consultant to Edwards Lifesciences and Medtronic. Dr. Toggweiler is a consultant and proctor for Boston Scientific and NVT GmbH; and has received an institutional research grant from Boston Scientific. Dr. Sondergaard has received consultant fees and institutional research grants from Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, and Symetis. Dr. Wood is a consultant to and has received research funding from Edwards Lifesciences and Abbott. Dr. Webb is a consultant to and has received research funding from Edwards Lifesciences, Abbott, and ViVitro Labs. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. ",

year = "2021",

month = mar,

day = "8",

doi = "10.1016/j.jcin.2020.10.030",

language = "אנגלית",

volume = "14",

pages = "586--588",

journal = "JACC: Cardiovascular Interventions",

issn = "1936-8798",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Long-Term Durability of the Next-Generation Acurate neo 2 Transcatheter Heart Valve

T2 - Insights From Bench Testing to 25 Years

AU - Sathananthan, Janarthanan

AU - Landes, Uri

AU - Flaction, Lionel

AU - Humair, Arnaud

AU - Delaloye, Stéphane

AU - Toggweiler, Stefan

AU - Søndergaard, Lars

AU - Wood, David A.

AU - Webb, John G.

N1 - Funding Information: This study was a purely bench study with no human or animal participants, and ethics approval was not required. No patient data were used in this study. Dr. Sathananthan is a consultant to Edwards Lifesciences and Medtronic. Dr. Toggweiler is a consultant and proctor for Boston Scientific and NVT GmbH; and has received an institutional research grant from Boston Scientific. Dr. Sondergaard has received consultant fees and institutional research grants from Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, and Symetis. Dr. Wood is a consultant to and has received research funding from Edwards Lifesciences and Abbott. Dr. Webb is a consultant to and has received research funding from Edwards Lifesciences, Abbott, and ViVitro Labs. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

PY - 2021/3/8

Y1 - 2021/3/8

UR - http://www.scopus.com/inward/record.url?scp=85101108613&partnerID=8YFLogxK

U2 - 10.1016/j.jcin.2020.10.030

DO - 10.1016/j.jcin.2020.10.030

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 33663791

AN - SCOPUS:85101108613

SN - 1936-8798

VL - 14

SP - 586

EP - 588

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

IS - 5

ER -

Long-Term Durability of the Next-Generation Acurate neo 2 Transcatheter Heart Valve: Insights From Bench Testing to 25 Years

Access to Document

Other files and links

Cite this